1. Volume 141, Issue 1, Pages 150-156 (July 2011)
Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies 
Michael Elashoff, Aleksey V. Matveyenko, Belinda Gier, Robert Elashoff, Peter C. Butler 
Gastroenterology 
Volume 141, Issue 1, Pages (July 2011)
DOI: /j.gastro
Copyright © 2011 AGA Institute Terms and Conditions

2. Figure 1
Odds ratio of test vs control events for exenatide, sitagliptin, and other therapies. The odds ratio of an adverse report of pancreatitis, pancreatic and thyroid cancer, or any cancer associated with exenatide and/or sitagliptin therapy vs other therapies.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2011 AGA Institute Terms and Conditions